Eurointervention

Papers
(The H4-Index of Eurointervention is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
TAVR under 70: is age just a number?244
International variation in modality and outcomes of left main revascularisation: does it really matter?130
Double-tap to treat paravalvular leak in high-risk annuli109
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity96
In search of the origin of the acronym TAVI93
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis80
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study79
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s71
Transcatheter left ventriculoplasty62
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis61
Recanalisation of coronary chronic total occlusions59
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement53
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry52
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure51
Defer-based non-stenting: a promising approach for STEMI49
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection48
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve46
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study44
   Atrial fibrillation and acute coronary syndrome 43
One-month DAPT after acute coronary syndrome: too short or not too short?41
The “road travelled”: reflections on the transformation of information exchange in a digital age41
Hybrid coronary revascularisation: the best or the worst of both worlds?41
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation37
Redo transcatheter mitral valve replacement in mitral annular calcification36
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document36
A novel robotic radiation shielding device for interventional cardiology procedures35
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons34
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes34
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial32
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD32
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial31
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study31
0.13990712165833